Please login to the form below

Not currently logged in
Email:
Password:

The Medicines Company strengthens board of directors

Paris Panayiotopoulos joins from ARIAD Pharmaceuticals

The Medicines Company has appointed Paris Panayiotopoulos to serve as a director and he's set to stand for election at the company’s 2017 annual meeting of stockholders.

Panayiotopoulos has held a number of previous leadership roles - most recently as president and chief executive officer and a member of the board of directors for ARIAD.

He said: “ I am delighted to be joining The Medicines Company, especially at such an important time.

“I look forward to working with the board in helping to support management in driving the company’s continued growth and success.”

Prior to joining ARIAD, Panayiotopoulos served as president of EMD Serono - the North American biopharmaceutical business of Merck KGaA - after serving as president of Merck Serono, Tokyo.

Clive Meanwell, chief executive officer and director of The Medicines Company, said: “We are pleased to welcome someone of Paris’s caliber to The Medicines Company board of directors.

“His strong leadership background will make him a valuable addition as we continue to execute on our strategic initiatives for the benefit of all shareholders.”

3rd April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics